{
  "report_rows": [
    {
      "kpi": "2Q26 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$2.622B vs. cons $2.590B.",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$1.405B vs. cons $1.370B.",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 AFFO per diluted share",
      "prediction": "BEAT",
      "answer": "pred ~$11.28 vs. cons $10.14.",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 revenue guidance",
      "prediction": "BETTER",
      "answer": "guide ~$10.30B vs. cons $10.24B (FY26).",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted EBITDA guidance",
      "prediction": "BETTER",
      "answer": "guide ~$5.29B vs. cons $5.23B (FY26).",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 AFFO per diluted share guidance",
      "prediction": "BETTER",
      "answer": "guide ~$43.40 vs. cons $43.05 (FY26).",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "A ~$43.40 FY26 AFFO/share guide versus ~$43.05 consensus supports a positive initial reaction, but the incremental raise is modest and reported 2Q strength includes the delayed Hampton contribution; investors are likely to shift toward 2027 core recurring-growth, capex and return math after the initial beat.",
  "day5_confidence": "MEDIUM"
}